-Livemint
India decides to frame policy that will incentivize local manufacturing of raw materials, bulk drugs
New Delhi: Six years back when China shut factories making drug ingredients to reduce pollution levels before Beijing Olympics, Indian bulk drug makers which depend on them suffered.
Now, India has decided to frame a policy which will incentivize local manufacturing of raw materials and bulk drugs, and discourage Indian pharmaceutical firms from importing them.
Please click here to read more.